<DOC>
	<DOCNO>NCT02288390</DOCNO>
	<brief_summary>Dental plaque score calculation swab Oropharynx teeth collect admission . For group I , Miswak stick use 4 hourly oral care . For group II , 0.12 % Chlorhexidine/ toothbrush use 4 hourly</brief_summary>
	<brief_title>Oral Care Preventive Measure VAP ; Miswak Versus Chlorhexidine Toothbrush .</brief_title>
	<detailed_description>The select patient randomize 2 group conventional method randomization . For patient follow parameter collect : patient data ; age , gender ; history smoking ; chronic health problem ; history drug steroid , chemotherapy , current antimicrobial therapy ; primary cause hospital ICU admission mechanical ventilation . Clinical examination include assessment disease severity admission Acute Physiology Chronic Health Evaluation ( APACHE II ) score system , oral dental examination , dental plaque score calculation . Oropharyngeal dental swab collect admission . The preventative VAP bundle apply patient group . For group I , Miswak use oral care , patient 's teeth brush every 4 hour use Miswak stick scrap half inch bark stick end Miswak tip wash compressed make brush like . Both buccal lingual surface teeth brush use mechanical method plaque removal ( direction away gingival margin , ) . The patient 's tongue brush possible lip moisturizer apply need . The brush like end sewak stick cut replace daily . For group II , patient 's teeth brush every 4 hour use soft toothbrush 0.12 % Chlorhexidine solution . Both buccal lingual surface teeth brush use mechanical method plaque removal ( direction away gingival margin , ) . The patient 's tongue brush possible lip moisturizer apply need . The toothbrush boil one minute every day . Patients group monitor efficacy oral care term plaque score halitosis . Colonization trachea , OPH , dental plaque potential respiratory pathogen ( PRPs ) Staphylococcus aureus , Pseudomonas , Klebsiella , Proteus , Acinetobacter E. coli specie identify culture OPH swab , dental swab endotracheal tube ( ETT ) aspirate inclusion study every 4 day thereafter till ICU discharge , 3 week ICU stay , death . Secondary endpoint include time VAP incidence , duration MV , ICU discharge , mortality rate . VAP diagnose patient develop ; new and/or progressive infiltrates chest radiograph plus two following ; leucocytosis ≥ 12000/mm3 leucopenia ≤ 4000c/mm3 , fever &gt; 38oC hypothermia &lt; 36oC , mucopurulent secretion evident gross inspection . The clinically diagnosed VAP confirm quantitative endotracheal aspirate cut value ≥105 colony form unit ( cfu ) /ml .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<criteria>Mechanically ventilate</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>VAP</keyword>
	<keyword>Oral care</keyword>
	<keyword>Chlorhexidine</keyword>
	<keyword>Miswak ( Sewak )</keyword>
</DOC>